Biosensors and biomolecular electronics represent powerful tools in biomedical diagnostics, healthcare monitoring, and personalized medicine. Recent ...

One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary cancers.

In this episode of Teach Me in 10, we’re joined by Thomas Quinn, Takara Bio USA R&D Group Leader, who introduces a ...

A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

The Rocky Mountain Regional Meeting (RMRM) is seeking abstract submissions for its 2025 meeting. The meeting will take place in Albuquerque, New Mexico, October 23–25, at the Hotel Albuquerque at Old ...

Sangamo Therapeutics Inc., a genomic medicine company, has entered into a license agreement with Eli Lilly and Company.

Lilly is the third company to partner with Sangamo on STAC-BBB after Astellas Gene Therapies, which paid $20 million upfront ...

Despite their advantages in compactness, power efficiency, and ease of integration, these devices are limited by nonlinear hysteretic effects inherent to piezoelectric transduction, which often lead ...

Sangamo Therapeutics shares are surging in Thursday's after-hours session after the company announced a new agreement with ...

Sangamo Therapeutics (SGMO) announced it has entered into a license agreement with Eli Lilly (LLY), allowing Lilly to leverage Sangamo’s novel ...

RICHMOND, CA, USA I April 03, 2025 I Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced it has entered into a license ...

Binding of miR-3036-5p to CYP18A1 can be prevented by an A-to-I RNA editing, thus elevating CYP18A1 expression, decreasing 20E titer, and finally regulating the wing dimorphism of offspring in aphid.